Cytoplasmic eIF6 promotes OSCC malignant behavior through AKT pathway.

Zechen ZhaoWeiming ChuYang ZhengChao WangYuemei YangTeng XuXueming YangWei ZhangXu DingGang LiHongchuang ZhangJunbo ZhouJinhai YeHeming WuXiaomeng SongYunong Wu

Published in: Cell communication and signaling : CCS (2021)

These results demonstrated that eIF6 could be a new therapeutic target in OSCC, thus providing a new basis for the prognosis of OSCC patients in the future. Video abstract.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
signaling pathway
prognostic factors
cell proliferation
current status
patient reported outcomes